retatrutide phase 3 trial results Biggest obesity news 🚨 TRIUMPH-1 are here: Retatrutide's showed up to 28% average weight loss over 80 weeks — with nearly half of patients losing over 30% of Retatrutide Phase 3 Updates: Significant

Disclaimer: This blog post is for informational purposes only and is not intended to replace medical advice

Ive had patients come back saying it stopped working

Some patients want the structure and convenience of a once-weekly injection

These medications have not been reviewed by the FDA for safety, efficacy, or quality

Betaine Supplementation Modulates Betaine Concentration by Methylenetetrahydrofolate Reductase Genotype, but Has No Effect on Amino Acid Profile in Healthy Active Males: A Randomized Placebo-Controlled Cross-over Study. Nutrition Research (New York, N.Y.) , vol

10.1016/j.neurobiolaging.2016.03.005 12 ClayH